Of the nine cases of grade 4 astrocytoma, IDH-mutant, four were classified based on pathological features (microvascular proliferation and necrosis), four were classified based on molecular features (CDKN2A/B HD), and one was classified based on both pathological and molecular feature. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).